Innovex International
INVX
26.92
-0.70
-2.53%
Innovex International
US · INVX
#2772 by market cap
Listed 1970
26.92
-0.70
-2.53%
Live - 5344 symbols - heartbeat 478s ago
· 2026-10-07 19:54
After-hours
26.92
0.00%
- Market cap
- 1.88B
- P/E (TTM)i
- 30.25
- P/Bi
- 1.78
- EPSi
- 1.20
- Div yieldi
- 0.00%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on INVX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.29, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +48.04% YoY
Margins
- Gross margin
- 31.00%
- Operating margin
- 11.63%
- Net margin
- 8.52%
Key ratios & quality
- PEG ratioi
- 3.15
- Altman Z-Scorei
- 7.29
PEG uses trailing P/E against the 3-year net income growth rate (9.60%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 294.84M | 467.19M | 555.54M | 660.80M | 978.25M |
| Gross profit | 87.40M | 158.12M | 195.44M | 232.63M | 303.28M |
| Selling & admin expenses | 55.58M | 59.19M | 72.80M | 116.18M | 128.79M |
| Research & development | -- | -- | -- | -- | -- |
| Operating profit | 14.08M | 80.46M | 99.98M | 85.24M | 113.75M |
| Pretax profit | 13.70M | 72.93M | 94.37M | 142.81M | 128.53M |
| Tax | 3.84M | 9.65M | 20.44M | 2.49M | 45.23M |
| Net profit | 9.85M | 63.28M | 73.93M | 140.33M | 83.30M |
| Basic EPS | 0 | 1 | 1 | 3 | 1 |
| Diluted EPS | 0.15 | 0.95 | 1.11 | 2.77 | 1.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 240.42M | 224.23M | 240.00M | 273.60M | 239.03M | 244.90M |
| Gross profit | 76.50M | 71.72M | 75.94M | 79.11M | 84.51M | 83.65M |
| Selling & admin expenses | 32.35M | 28.84M | 35.57M | 32.04M | 41.75M | 39.09M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 29.21M | 27.91M | 25.01M | 31.62M | 26.54M | 28.35M |
| Pretax profit | 21.36M | 22.24M | 57.96M | 26.97M | -21.59M | 35.41M |
| Tax | 6.61M | 6.89M | 18.73M | 13.00M | -4.92M | 10.38M |
| Net profit | 14.76M | 15.35M | 39.23M | 13.97M | -16.67M | 25.03M |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 0 |
| Diluted EPS | 0.21 | 0.22 | 0.57 | 0.20 | -0.24 | 0.36 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 192.91M | 282.39M | 288.27M | 641.39M | 728.05M |
| Cash & ST investments | 9.74M | 8.42M | 7.41M | 73.28M | 203.41M |
| Inventory | 92.29M | 136.66M | 141.19M | 271.17M | 248.43M |
| Total assets | 284.90M | 436.29M | 475.30M | 1.20B | 1.27B |
| Total current liabilities | 69.57M | 85.02M | 78.62M | 162.66M | 148.16M |
| Short-term debt | 5.80M | 14.66M | 17.18M | 21.01M | 19.38M |
| Long-term debt | 31.24M | 76.40M | 35.25M | 20.02M | -- |
| Total liabilities | 104,344,000.00 | 185,006,000.00 | 146,379,000.00 | 239,327,000.00 | 210,608,000.00 |
| Total equity | 180.55M | 251.28M | 328.92M | 958.16M | 1.06B |
| Retained earnings | 8.70M | 71.98M | 145.91M | 211.25M | 285.27M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 632.64M | 670.11M | 710.35M | 728.05M | 752.89M | 788.53M |
| Cash & ST investments | 68.12M | 68.78M | 163.37M | 203.41M | 200.71M | 222.06M |
| Inventory | 269.25M | 278.50M | 275.20M | 248.43M | 252.99M | 264.84M |
| Total assets | 1.20B | 1.23B | 1.25B | 1.27B | 1.29B | 1.33B |
| Total current liabilities | 145.82M | 145.75M | 148.71M | 148.16M | 147.76M | 157.52M |
| Short-term debt | 17.09M | 18.28M | 19.10M | 19.38M | 18.81M | 18.78M |
| Long-term debt | 14.60M | 27.64M | -- | -- | -- | -- |
| Total liabilities | 217,627,000.00 | 231,528,000.00 | 214,956,000.00 | 210,608,000.00 | 256,772,000.00 | 269,248,000.00 |
| Total equity | 978.38M | 995.55M | 1.04B | 1.06B | 1.03B | 1.06B |
| Retained earnings | 225.38M | 232.08M | 271.31M | 285.27M | 254.48M | 279.51M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -2.03M | -5.81M | 75.86M | 93.44M | 190.91M |
| Depreciation & amortization | 17.74M | 24.96M | 30.06M | 39.52M | 73.24M |
| Free cash flow | -8.47M | -15.39M | 60.38M | 79.85M | 155.78M |
| Dividends paid | -- | 0 | 0 | -74.98M | 0 |
| Stock buybacks / issuance | -331.00K | -1.29M | 0 | 0 | -9.28M |
| Ending cash balance | 9.74M | 8.42M | 7.41M | 73.28M | 203.41M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 31.09M | 59.21M | 48.37M | 52.24M | 19.84M | 37.03M |
| Depreciation & amortization | 17.88M | 18.01M | 18.62M | 18.73M | 19.50M | 19.53M |
| Free cash flow | 24.03M | 51.91M | 36.52M | 43.31M | 14.01M | 30.39M |
| Dividends paid | -- | -- | -- | 0 | -- | -- |
| Stock buybacks / issuance | -626.00K | -8.65M | 0 | 0 | -14.13M | 1.00K |
| Ending cash balance | 68.12M | 68.78M | 163.37M | 203.41M | 200.71M | 222.06M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | 5.46 | 29.31 | 25.48 | 21.81 | 8.26 |
| ROA %i | 3.46 | 17.55 | 16.22 | 16.78 | 6.76 |
| ROIC %i | 5.19 | 22.81 | 20.07 | 19.51 | 7.77 |
| 5-year avg ROE %i | -- | -- | -- | -- | 18.06 |
| EBIT margin %i | 5.38 | 16.47 | 17.98 | 21.98 | 13.40 |
| FCF / sales %i | -- | -- | 10.87 | 12.08 | 15.92 |
| Current ratioi | 2.77 | 3.32 | 3.67 | 3.94 | 4.91 |
| Quick ratioi | 1.33 | 1.58 | 1.65 | 2.09 | 3.13 |
| Debt / assetsi | 13.77 | 26.26 | 17.86 | 7.61 | 6.25 |
| LT debt / equityi | 18.51 | 39.77 | 20.59 | 7.31 | 5.66 |
| Interest coveragei | 7.35 | 19.08 | 18.14 | 59.77 | 50.78 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 30.87 | 27.93 |
| Net income CAGR (3Y) %i | -- | -- | -- | 142.39 | 9.60 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 14.17 | 14.51 | 10.41 | 8.26 | 5.16 | 5.99 |
| ROA %i | 11.59 | 11.77 | 8.47 | 6.76 | 4.18 | 4.82 |
| ROIC %i | 13.29 | 13.41 | 9.82 | 7.77 | 4.78 | 5.53 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 18.76 | 17.69 | 13.74 | 13.40 | 13.15 | 14.15 |
| FCF / sales %i | 12.12 | 14.38 | 14.78 | 15.92 | 14.92 | 12.45 |
| Current ratioi | 4.34 | 4.60 | 4.78 | 4.91 | 5.10 | 5.01 |
| Quick ratioi | 2.31 | 2.23 | 2.79 | 3.13 | 3.25 | 3.16 |
| Debt / assetsi | 6.92 | 8.04 | 6.58 | 6.25 | 5.92 | 5.62 |
| LT debt / equityi | 6.71 | 8.08 | 6.10 | 5.66 | 5.57 | 5.27 |
| Interest coveragei | 60.16 | 65.12 | 57.00 | 50.78 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.